| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 09/02/2004 | US20040171007 Using oligonuclleotide and DNA amplification to identify mycobacterium in biological samples; clinical diagnostics |
| 09/02/2004 | US20040170958 Viral drug susceptibility testing |
| 09/02/2004 | DE102004006526A1 Neues Lysindecarboxylase-Gen und Verfahren zur Herstellung von L-Lysin New lysine decarboxylase gene, and methods for producing L-lysine |
| 09/02/2004 | CA2516527A1 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 09/01/2004 | EP1452588A1 Reductase gene and use of the same |
| 09/01/2004 | EP1452585A1 Gamma-glutamylcysteine-producing yeast and method of screening the same |
| 09/01/2004 | EP1452542A2 Reshaped human monoclonal antibodies specific for IgE |
| 09/01/2004 | EP1451338A1 Recombinant antibodies for the detection and neutralization of anthrax toxin |
| 09/01/2004 | EP1451334A2 Production of alpha-keto butyrate |
| 09/01/2004 | EP1451328A2 Phytases and method for producing these phytases |
| 09/01/2004 | EP0937139B1 Amidase |
| 09/01/2004 | EP0764172B1 Synthetic peptide analogs of lung surfactant protein sp-c |
| 09/01/2004 | EP0616640B1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 09/01/2004 | EP0610254B1 Glial derived neurotrophic factor |
| 09/01/2004 | CN1526018A Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/01/2004 | CN1526017A Gene associated with leishmania parasite virulence |
| 09/01/2004 | CN1526010A Bacterial host strains |
| 09/01/2004 | CN1164761C Process for producing product contg. antihypertensive tripeptides |
| 09/01/2004 | CN1164756C Nucleic acid transporter containing polypeptide and recombinant virus vector |
| 08/31/2004 | US6784157 Peptide activates dna binding of wild-type p53 or a p53 mutant containing a single amino acid substitution; a peptidomimetic consisting of four sequential amino acids from a negative regulatory region; anticarcinogenic, -tumor agents |
| 08/31/2004 | US6783981 Capable of delivering anti-viral inhibitory rna molecules to target cells; gene therapy |
| 08/31/2004 | US6783966 For diagnosis and treatment of diseases; for production of glycolipids |
| 08/31/2004 | US6783958 Generating biosensor protein; determine sequence of fluorescent protein, generate fusion protein, incubate with modulator, detect conformational adjustments, monitor adjustments in fluorescence |
| 08/31/2004 | US6783956 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 08/31/2004 | US6783952 Deleting portion of eukaryotic nucleotide sequence encoding cerebral cortical voltage-dependent calcium channel alpha 2 subunit yielding soluble secreted protein retaining affinity for (3h)gabapentin |
| 08/31/2004 | US6783951 Process for production of carotenoids, xanthophylls and apo-carotenoids utilizing eukaryotic microorganisms |
| 08/31/2004 | US6783751 Method for labeling biopolymers using isotopes |
| 08/31/2004 | CA2061362C Method for producing human nerve growth factor-2 |
| 08/26/2004 | WO2004071382A2 Substituted heterocycles |
| 08/26/2004 | US20040167074 Therapeutic applications of mFLINT polypeptides |
| 08/26/2004 | US20040166580 Vector constructs |
| 08/26/2004 | US20040166576 Fungi and their symbiotic bacterial group suitable for treating organic waste, and uses thereof |
| 08/26/2004 | US20040166564 D-aminoacylase and gene encoding the same |
| 08/26/2004 | US20040166486 RNA three dimensional structure (pseudoknot) which stimulates/activates protein synthesis; enhancement of cell-free translation of heterologous polypeptides |
| 08/26/2004 | US20040166141 Methods and devices for modulating the immune response |
| 08/26/2004 | US20040166116 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 08/26/2004 | DE10305774A1 Verfahren zur fermentativen Herstellung von L-Methionin A process for the fermentative preparation of L-methionine |
| 08/25/2004 | EP1449923A1 Novel formate dehydrogenase tolerant to halogen compounds and process for producing the same |
| 08/25/2004 | EP1449921A2 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 08/25/2004 | EP1449917A1 PROCESS FOR PRODUCING L−AMINO ACID USING ESCHERICHIA |
| 08/25/2004 | EP1449913A1 Gamma-glutamylcysteine-producing yeast |
| 08/25/2004 | EP1449849A2 Protease-resistant thrombomodulin analog |
| 08/25/2004 | EP1449814A1 Fungi and their symbiotic bacterial group suitable for treating organic waste, and uses thereof |
| 08/25/2004 | EP1449427A1 Rooted cutting and method of inoculating rooted cutting with microbial strain |
| 08/25/2004 | EP1448784A1 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/25/2004 | EP1448595A1 Antimicrobial polypeptides from pseudoplectania nigrella |
| 08/25/2004 | EP1148139B1 Variant luciferase, variant luciferase gene, novel recombinant dna and process for producing variant luciferase |
| 08/25/2004 | EP1002098B1 Mutant alpha-amylase having introduced therein a disulfide bond |
| 08/25/2004 | EP0942068B1 Process for the preparation of optically active n-benzyl-3-pyrrolidinol |
| 08/25/2004 | EP0839054B1 Tissue or cell-specific herpes simplex virus replication |
| 08/25/2004 | EP0724632B1 Stem cell proliferation factor |
| 08/25/2004 | EP0711361B1 5' nucleases derived from thermostable dna polymerase |
| 08/25/2004 | EP0700441B1 Multiple sclerosis virus |
| 08/25/2004 | CN1523116A Preparation of a macrocyclic lactone |
| 08/25/2004 | CN1163754C Method for diagnosing a patient for chlamydia |
| 08/25/2004 | CN1163615C Method for producing L-carnitine from crotonobetaine |
| 08/25/2004 | CN1163611C Self-reproduced plasmid in bar shaped bacteria |
| 08/25/2004 | CN1163607C Polypeptide with aminopeptidase activity and its coded nucleic acid |
| 08/25/2004 | CN1163600C Process for preparing human proinsulin |
| 08/25/2004 | CN1163597C Alpha-amylase mutant |
| 08/25/2004 | CN1163596C Common phytase |
| 08/25/2004 | CN1163593C Genetic engineering L-sorbose reductase deficient mutant |
| 08/24/2004 | US6780983 Polypeptide having water channel activity and DNA sequence |
| 08/24/2004 | US6780976 Enzymatic polypeptide for use in the generation of pharmeceuticals |
| 08/24/2004 | US6780890 Contacting s-adenosylhomocysteine (sah with a luxs protein whereby s- adenosylhomocysteine undergoes conversion to autoinducer-2 |
| 08/24/2004 | US6780624 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 08/24/2004 | US6780619 D-aminoacylase and gene encoding the same |
| 08/24/2004 | US6780611 G protein coupled receptors; drug screening |
| 08/24/2004 | US6780420 Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccine |
| 08/24/2004 | US6780419 Isolated polypeptide comprising specified amino acid sequence or immunogenic fragment of at least 15 contiguous amino acids, which when administered to subject induces antibody or t-cell mediated immune response that recognizes polypeptide |
| 08/24/2004 | US6780406 Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene |
| 08/24/2004 | US6780405 Having first origin of replication conferring low copy number, conferring vector replication using dna polymerase iii, second origin of replication operably linked to first promoter and repressed by chromosome-encoded repressor, as is foreign gene |
| 08/24/2004 | US6780317 Method of purifying water, suitable bacteria for the method and use thereof |
| 08/24/2004 | CA2061148C Glia activating factor and its production |
| 08/19/2004 | WO2004070022A2 Use of oxalate deficient aspergillus niger strains for producing a polypeptide |
| 08/19/2004 | WO2004069983A2 Microreactor architecture and methods |
| 08/19/2004 | WO2004069178A2 Anti-inflammatory activity from lactic acid bacteria |
| 08/19/2004 | WO2004048597A3 Composition and method for inhibition of microorganisms |
| 08/19/2004 | US20040163136 SEL-12 related methods |
| 08/19/2004 | US20040162417 Nucleotide sequences coding metalloenzyme for use in detergents, therapeutic, cosmetics, leather processing, solubilizing or softening agents, foods, meat modifiers, feeds and oil and fat seperating agents |
| 08/19/2004 | US20040161816 Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| 08/19/2004 | US20040161771 Using fluorescence activated cell sorting to identify and separate cell expressing nucleotide sequence coding transcribing interleukin-4 |
| 08/19/2004 | US20040161420 Designed for bacterial live vector vaccines; does not rely on antibiotic resistance; stability |
| 08/19/2004 | CA2513833A1 Use of oxalate deficient aspergillus niger strains for producing a polypeptide |
| 08/19/2004 | CA2496017A1 Microreactor architecture and methods |
| 08/18/2004 | EP1446506A2 COMPOSITIONS, METHODS AND KITS FOR DETERMINING THE PRESENCE OF i MYCOPLASMA PNEUMONIAE /i AND/OR i MYCOPLASMA GENITALIUM /i IN A TEST SAMPLE |
| 08/18/2004 | EP1446417A2 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 08/18/2004 | EP1446012A1 Combination bacteriolytic therapy for the treatment of tumors |
| 08/18/2004 | EP1194562B1 The lactose operon of lactobacillus delbrueckii and its use for controlling gene transcription and/or expression in bacterial cells |
| 08/18/2004 | EP1062059B1 Bacterium capable of biodegradation of wastes |
| 08/18/2004 | EP1060240B1 Lactobacillus strain |
| 08/18/2004 | EP1053474B1 Method for the determination of prosthetic infections |
| 08/18/2004 | EP0977856B1 Lag-3 splice variants |
| 08/18/2004 | EP0871474A4 Generation of human insulin |
| 08/18/2004 | EP0820507B1 Ndf peptides |
| 08/18/2004 | EP0817851B9 Dna encoding human papilloma virus type 18 |
| 08/18/2004 | EP0804587B1 Mutant luciferases |
| 08/18/2004 | EP0471011B2 HUMAN LACTOFERRIN cDNA SEQUENCE |
| 08/18/2004 | CN1522305A Amplification process |
| 08/18/2004 | CN1521264A Process for preparing serine-rich protein employing cysteine synthase (cysk) gene |